Role of 99mTc-Bombesin Scan in Diagnosis and Staging of Prostate Cancer

Cancer Biotherapy and Radiopharmaceuticals

Volumn 19, Issue 1, 2004, Pages 81-84

  De Vincentis, Giuseppe ^a   Remediani, Silvia ^a   Varvarigou, Alexandra D ^b   Di Santo, Gianpaolo ^a   Iori, Francesco ^a   Laurenti, Cesare ^a   Scopinaro, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

99mTc Bombesin; Lymph nodes detection; Prostate cancer; Prostate cancer scintigraphy

Indexed keywords

BOMBESIN TC 99M; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; BOMBESIN; DIAGNOSTIC AGENT; TECHNETIUM;

CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DRUG UPTAKE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INGUINAL LYMPH NODE; ISOTOPE LABELING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE ADENOMA; PROSTATE BIOPSY; PROSTATE CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSRECTAL ULTRASONOGRAPHY; ARTICLE; CLINICAL TRIAL; ECHOGRAPHY; IMAGE PROCESSING; LYMPH NODE METASTASIS; PATHOLOGY; PROSTATE TUMOR; SCINTISCANNING;

BOMBESIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 1642446676     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497804773391711     Document Type: Conference Paper

References (18)

1. Yu KK, Hricak H. Imaging prostate cancer. Radiol Clin North Am 2000;38(1):59.
2. Tanaka N, Samma S, Joko M, et al. Diagnostic usefulness of endorectal magnetic resonance imaging with dynamic contrast-enhancement in patients with localized prostate cancer: mapping studies with biopsy specimens. Int J Urol 1999;6(12):593.
3. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000;55(2):99.
4. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 1999;213(2):473.
5. Hricak H, Dooms GC, Jeffrey RB, et al. Prostatic carcinoma: Staging by clinical assessment, CT, and MR imaging. Radiology 1987;162(2):331.
6. Platt JF, Bree RL, Schwab RE. The accuracy of CT in the staging of carcinoma of the prostate. Am J Roentgenol 1987;149(2):315.
7. Jager GJ, Barentsz JO, Oosterhof GO, et al. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. Am J Roentgenol 1996;167(6):1503.
8. Sartor O, McLeod D. Indium-111-capromab pendetide scans: An important test relevant to clinical decision making. Urology 2001;57(3):399.
9. Lange PH. PROSTASCINT scan for staging prostate cancer. Urology 2001;57(3):402.
10. Markwalder R, Reubi JC. Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation. Cancer Res 1999;1;59(5):1152.
11. Sun B, Halmos G, Schally AV, et al. Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers. Prostate 2000;1;42(4):295.
12. Scopinaro F, Varvarigou AD, Ussof W, et al. Technetium labeled bombesin-like peptide: preliminary report on breast cancer uptake in patients. Cancer Biother Radiopharm 2002;17(3):327.
13. De Vincentis G, Scopinaro F, Varvarigou A, et al. Phase I trial of technetium [Leul3] bombesin as cancer seeking agent: possible scintigraphic guide for surgery? Tumori 2002;88(3):S28.
14. Perrotti M, Han KR, Epstein RE, et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: A pilot study. J Urol 1999;162(4):1314.
15. Aprikian AG, Tremblay L, Han K, Chevalier S. Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. Int J Cancer 1997;29;72(3):498.
16. Bologna M, Festuccia C, Muzi P, et al. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 1989;1;63(9):1714.
17. Jungwirth A, Pinski J, Galvan G, et al. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II. Eur J Cancer 1997;33(7):1141.
18. Gugger M, Reubi JC. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Am J Pathol 1999;155(6):2067.